Cardiomegaly, also called an enlarged heart, is a serious medical epidemic that affects many people worldwide. Factors like high blood pressure, heart disease, or other underlying health deficits contribute to the development and progression of the condition. Emerging treatments in the last decade or so have offered hope to people; however, with these advancements come important ethical questions. Who should be the recipient of these treatments? How can patients fully understand the risks? What are the consequences of the treatment in the long term?

Advanced medical treatments and the ethical regulations that govern them are constantly evolving, especially when the debate is on debilitating diseases like cardiomegaly (an enlarged heart). 

This article attempts to shed light on the ethical considerations surrounding these advanced treatments, focusing on patient rights, fairness, safety, and the responsibility of healthcare providers.

Advanced heart devices: A brief overview

Figure 1. A timeline highlighting key innovations in heart devices from the 1950s to today.

Pacemakers, Implantable cardioverter defibrillators (ICDs), and artificial hearts have been the front-line treatment options for decades, starting with pacemakers in 1957, and progressing to more complex systems like left ventricular assist devices (LVADs) and full artificial hearts.¹ These devices undoubtedly have been life-changing to patients who would otherwise face terminal heart failure. But as technology has advanced, so too have the ethical challenges.

Core ethical principles at play

The entire ethical landscape and its decision-making in medicine revolves around four core principles: autonomy, beneficence, non-maleficence, and justice. These principles dictate the terms of action that doctors and patients undertake while making judgments over a course of treatment.² However, as heart devices become more intricate and patients face life-altering decisions about their use, ethical conflicts can arise.

Table 1. Application of principles of ethics in patient care

Autonomy

Autonomy centres around a patient’s right to make informed decisions concerning their health. Alternatively, this can be best explained as the treatment receiver’s ability to control their choices. This is possible only when they are fully aware of the various options available, and this is crucial for advanced treatments.

Beneficence and non-maleficence

Doctors are expected to act in the best interests of their patients. This principle is called beneficence. At the same time, doctors must also ensure they are not causing unnecessary harm to their patients, a principle known as non-maleficence.

Justice

Justice in healthcare refers to fairness, ensuring that everyone has equal access to treatments and that resources are distributed fairly. When it comes to advanced treatments for enlarged hearts, this can be particularly challenging. Heart transplants, for instance, require donor organs, which are in limited supply. Gene therapies and mechanical devices can be extremely expensive, raising questions about who can afford these treatments and whether everyone has equal access.

Ethical conflicts: when principles collide

A recent article in the Journal of Medical Ethics presents a debate over whether and when heart devices like ICDs can be deactivated, highlighting how ethical principles can collide.³ Is it up to the doctor to deactivate an ICD if they believe further shocks are futile? Can a patient’s request to turn off the device override the doctor's belief in the potential for continued benefit?

Case study: deactivation of ICDs

Figure 2. A flowchart showing decision pathways when considering ICD deactivation, with patient autonomy and medical futility at opposing ends of the spectrum.

ICDs are designed to prevent sudden cardiac death by delivering shocks when abnormal heart rhythms are detected. However, for patients nearing the end of life or experiencing severe discomfort from frequent shocks, the device may feel more like a burden than a life-saving intervention. In these cases, the patient may request deactivation, invoking their right to autonomy. But doctors may hesitate, concerned that turning off the device would constitute an act of omission akin to euthanasia.

This raises a significant ethical dilemma:

• Autonomy: Should the patient have the right to deactivate the device?
• Futility: Should the doctor, who deems the treatment futile, also have the right to deactivate it without the patient’s consent?

England et al.⁴ argue that both the patient and the doctor have the right to terminate ICD therapy, but only if certain conditions are met. This case illustrates the broader ethical challenge of when to discontinue life-sustaining devices and who should make that decision.

The spectrum of implantable heart devices and their ethical considerations

The use of implantable heart devices for end-stage heart failure has sparked essential debates about the balance between what we can do and what we should do. While advanced devices such as ICDs, Cardiac Resynchronisation Therapy (CRT), and Ventricular Assist Devices (VADs) offer life-saving benefits, their use isn't always in the best interest of every patient. In some cases, device implantation may not avoid harm, respect patient autonomy, or promote a fair and equitable distribution of healthcare resources.⁵

Patients receiving these devices may face significant decrements in their quality of life, sometimes finding themselves worse off after implantation. Common examples include inappropriate ICD shocks, strokes from blood clots in VAD recipients, or psychological challenges like depression and anxiety. These factors, which are often not fully explained to patients prior to implantation, highlight a critical ethical consideration: informed consent.

Informed consent and quality of life discussions

Figure 3. An infographic contrasting patient expectations vs. the reality of living with heart devices.

Informed consent is a cornerstone of ethical medical practice, especially in the context of advanced treatments like implantable heart devices. To ensure truly informed decisions, a strong healthcare provider–patient relationship is essential, along with clear and continuous communication. The process of informed consent should follow a three-step approach:^{2, 6}

1. Accurate Information: The patient must receive clear, understandable information about their condition, prognosis, the nature of any proposed interventions, alternatives, and the associated risks and benefits
2. Assessment of Understanding: The patient should then paraphrase the information they've been given. This allows the healthcare provider to assess their understanding and correct any misconceptions, ensuring that the patient is fully aware of the implications
3. Deliberation and Decision-Making: Finally, the patient needs time to deliberate and choose among the available alternatives. The decision they make should reflect their personal values and priorities, and they should be able to justify their choice with clarity

Studies have shown that many patients lack a comprehensive understanding of the benefits and burdens of device therapy, making this process of informed consent even more critical.⁷ Without it, patients might agree to procedures without fully grasping how these devices might impact their quality of life. 

Furthermore, psychological issues such as depression and anxiety, common among heart failure patients, can worsen post-implantation. It has also been suggested that certain personality traits may predispose some patients to higher levels of anxiety, making their psychological risk profile a crucial consideration before any device implantation.⁸

Ultimately, these conversations—focused not just on the clinical outcomes but also on quality of life and end-of-life planning—should be ongoing. As a patient’s illness progresses, their preferences may change, making it essential to regularly revisit the discussion around the continuation or deactivation of these devices.

Navigating ethical dilemmas: A shared decision-making model

One approach to resolving these ethical dilemmas is through shared decision-making, where patients, their families, and healthcare providers work together to reach a consensus on treatment. This collaborative process ensures that the patient’s values and wishes are respected, while also considering the medical realities of their condition.^{2, 9}

• Patients: Should be fully informed of the risks, benefits, and possible outcomes
• Physicians: Must provide clear, honest assessments of the patient’s prognosis and the potential futility of continued treatment
• Families: Can offer support and help ensure that the patient’s wishes are honoured, especially when the patient is no longer able to make decisions

Shared decision-making can help balance the principles of autonomy, beneficence, and futility, and can lead to more ethically sound outcomes, even in complex cases.

The emergence of cardioethics in advanced heart failure treatment

The rapid advancements in heart failure treatments have brought new ethical challenges, giving rise to what can be termed "cardioethics."⁵ With more patients surviving longer due to devices like ICDs, CRTs, and VADs, there is an increasing need to weigh the tradeoff between quality of life and the extension of life.

The ethical dilemmas extend beyond clinical outcomes to include cost-benefit considerations. As healthcare resources become more constrained, doctors and healthcare plans may need to deny certain costly treatments, even if they provide some benefit, because the cost outweighs the expected improvement in quality of life.

Integrating cardioethics into medical training

Fields et al.⁵ also suggest that cardioethics should be formally incorporated into medical and allied health training. Multidisciplinary education is essential, with cardiologists needing to learn how to make decisions that respect patient autonomy while also considering resource limitations. Training programs should emphasise when to accept inevitable death and when advanced interventions may no longer be appropriate, helping healthcare providers navigate these complex ethical landscapes.

In the era of healthcare reform, integrating ethical reflection into treatment decisions is not just necessary—it’s crucial.

Summary

As advanced treatments for cardiomegaly (enlarged heart) like ICDs, VADs, and artificial hearts become more common, they raise critical ethical concerns. Central to these concerns are the core medical ethics principles: autonomy, beneficence, non-maleficence, and justice. Key dilemmas include patients’ rights to deactivate life-sustaining devices, ensuring fair access to expensive treatments, and whether the benefits outweigh the burdens of these technologies. Issues like informed consent, quality of life, and shared decision-making are crucial in navigating these challenges. The emerging field of cardioethics calls for healthcare professionals to balance medical possibilities with ethical responsibilities, including integrating these principles into medical training.